Reproductive factors and exogenous hormone use in relation to risk of glioma and meningioma in a large European cohort study

Cancer Epidemiology Biomarkers and Prevention

Volumn 19, Issue 10, 2010, Pages 2562-2569

  Michaud, Dominique S ^a,b   Gallo, Valentina ^a   Schlehofer, Brigitte ^c   Tjønneland, Anne ^f   Olsen, Anja ^f   Overvad, Kim ^d   Dahm, Christina C ^d,e   Kaaks, Rudolf ^c   Lukanova, Annekatrin ^c   Boeing, Heiner ^g   Schütze, Madlen ^g   Trichopoulou, Antonia ^h,j   Bamia, Christina ^h   Kyrozis, Andreas ^i,j   Sacerdote, Carlotta ^k   Agnoli, Claudia ^l   Palli, Domenico ^m   Tumino, Rosario ⁿ   Mattiello, Amalia ^o   Bueno de Mesquita, H Bas ^p   Ros, Martine M ^p,q   Peeters, Petra H M ^u,v   Van Gils, Carla H ^r   Lund, Eiliv ^s   Bakken, Kjersti ^s   Gram, Inger T ^s   Barricarte, Aurelio ^t,u   Navarro, Carmen ^u,v   Dorronsoro, Miren ^u   Sánchez, Maria José ^u,w   Rodríguez, Laudina ^x   Duell, Eric J ^y   Hallmans, Göran ^z   Melin, Beatrice S ^aa   Manjer, Jonas ^ab   Borgquist, Signe ^ab   Khaw, Kay Tee ^ad   Wareham, Nick ^ae   Allen, Naomi E ^ac   Tsilidis, Konstantinos K ^ac   Romieu, Isabelle ^af   Rinaldi, Sabina ^af   Vineis, Paolo ^a   Riboli, Elio ^a   more..

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b BROWN UNIVERSITY   (United States)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d AARHUS UNIVERSITY   (Denmark)

^e AARHUS UNIVERSITY HOSPITAL   (Denmark)

^f INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^g GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^h WHO Collaborating Center for Food and Nutrition Policies   (Italy)

ⁱ NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^j HELLENIC HEALTH FOUNDATION   (Greece)

^k CPO Piemonte   (Italy)

^l NATIONAL CANCER INSTITUTE   (Italy)

^m CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

ⁿ CIVILE M P AREZZO HOSPITAL   (Italy)

^o UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^p NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^q RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^r UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^s UNIVERSITY OF TROMSØ   (Norway)

^t INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^u CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^v Regional Health Authority   (Spain)

^w ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^x Health and Health Care Services Council   (Spain)

^y CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^z UMEÅ UNIVERSITY   (Sweden)

^aa UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^ab LUND UNIVERSITY HOSPITAL   (Sweden)

^ac UNIVERSITY OF OXFORD   (United Kingdom)

^ad UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^ae MRC EPIDEMIOLOGY UNIT   (United Kingdom)

^af INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; CANCER RISK; CLINICAL TRIAL; DISEASE ASSOCIATION; EUROPE; FEMALE; FOLLOW UP; GLIOMA; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MENARCHE; MENINGIOMA; MENOPAUSE; MULTICENTER STUDY; ONSET AGE; PARITY; POSTMENOPAUSE; PRIORITY JOURNAL; REPRODUCTIVE HISTORY;

BRAIN NEOPLASMS; COHORT STUDIES; CONTRACEPTIVES, ORAL; EUROPE; FEMALE; GLIOMA; HORMONE REPLACEMENT THERAPY; HUMANS; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; PREGNANCY; PROSPECTIVE STUDIES; REPRODUCTIVE HISTORY;

EID: 77958069027     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-10-0447     Document Type: Article

References (32)

1. Wrensch M, Jenkins RB, Chang JS, et al. Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat Genet 2009;41:905-8.
2. Shete S, Hosking FJ, Robertson LB, et al. Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet 2009;41:899-904.
3. CBTRUS. Statistical Report: Primary Brain Tumors in the United States, 1998-2002. Central Brain Tumor Registry of the United States; 2005.
4. Koper JW, Lamberts SW. Meningiomas, epidermal growth factor and progesterone. Hum Reprod 1994;9 Suppl 1:190-4.
5. Rao G, Giordano SH, Liu J, McCutcheon IE. The association of breast cancer and meningioma in men and women. Neurosurgery 2009;65:483-9.
6. Lee E, Grutsch J, Persky V, Glick R, Mendes J, Davis F. Association of meningioma with reproductive factors. Int J Cancer 2006;119:1152-7.
7. Wigertz A, Lonn S, Mathiesen T, Ahlbom A, Hall P, Feychting M. Risk of brain tumors associated with exposure to exogenous female sex hormones. Am J Epidemiol 2006;164:629-36.
8. Wigertz A, Lonn S, Hall P, et al. Reproductive factors and risk of meningioma and glioma. Cancer Epidemiol Biomarkers Prev 2008;17:2663-70.
9. Huang K, Whelan EA, Ruder AM, et al. Reproductive factors and risk of glioma in women. Cancer Epidemiol Biomarkers Prev 2004;13:1583-8.
10. Hatch EE, Linet MS, Zhang J, et al. Reproductive and hormonal factors and risk of brain tumors in adult females. Int J Cancer 2005;114:797-805. (Pubitemid 40344441)
11. Custer B, Longstreth WT, Jr., Phillips LE, Koepsell TD, Van Belle G. Hormonal exposures and the risk of intracranial meningioma in women: a population-based case-control study. BMC Cancer 2006;6:152.
12. Cantor KP, Lynch CF, Johnson D. Reproductive factors and risk of brain, colon, and other malignancies in Iowa (United States). Cancer Causes Control 1993;4:505-11.
13. Cicuttini FM, Hurley SF, Forbes A, et al. Association of adult glioma with medical conditions, family and reproductive history. Int J Cancer 1997;71:203-7. (Pubitemid 27252991)
14. Hochberg F, Toniolo P, Cole P, Salcman M. Nonoccupational risk indicators of glioblastoma in adults. J Neurooncol 1990;8:55-60.
15. Schlehofer B, Blettner M, Wahrendorf J. Association between brain tumors and menopausal status. J Natl Cancer Inst 1992;84:1346-9.
16. Felini MJ, Olshan AF, Schroeder JC, et al. Reproductive factors and hormone use and risk of adult gliomas. Cancer Causes Control 2009;20:87-96.
17. Lambe M, Coogan P, Baron J. Reproductive factors and the risk of brain tumors: a population-based study in Sweden. Int J Cancer 1997;72:389-93. (Pubitemid 27325862)
18. Silvera SA, Miller AB, Rohan TE. Hormonal and reproductive factors and risk of glioma: a prospective cohort study. Int J Cancer 2006;118:1321-4.
19. Jhawar BS, Fuchs CS, Colditz GA, Stampfer MJ. Sex steroid hormone exposures and risk for meningioma. J Neurosurg 2003;99:848-53.
20. Benson VS, Pirie K, Green J, Casabonne D, Beral V. Lifestyle factors and primary glioma and meningioma tumours in the Million Women Study cohort. Br J Cancer 2008;99:185-90.
21. Blitshteyn S, Crook JE, Jaeckle KA. Is there an association between meningioma and hormone replacement therapy? J Clin Oncol 2008;26:279-82.
22. Benson VS, Pirie K, Green J, et al. Hormone replacement therapy and incidence of central nervous system tumours in the million women study. Int J Cancer 2010;127:1692-8.
23. Riboli E, Hunt KJ, Slimani N, et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 2002;5:1113-24.
24. Allen NE, Key TJ, Dossus L, et al. Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr Relat Cancer 2008;15:485-97.
25. Saitoh Y, Oku Y, Izumoto S, Go J. Rapid growth of a meningioma during pregnancy: relationship with estrogen and progesterone receptors-case report. Neurol Med Chir (Tokyo) 1989;29:440-3. (Pubitemid 19199072)
26. Wan WL, Geller JL, Feldon SE, Sadun AA. Visual loss caused by rapidly progressive intracranial meningiomas during pregnancy. Ophthalmology 1990;97:18-21.
27. Bickerstaff ER, Small JM, Guest IA. The relapsing course of certain meningiomas in relation to pregnancy and menstruation. J Neurol Neurosurg Psychiatry 1958;21:89-91.
28. Gazzeri R, Galarza M, Gazzeri G. Growth of a meningioma in a transsexual patient after estrogen-progestin therapy. N Engl J Med 2007;357:2411-2. (Pubitemid 350223416)
29. Jay JR, MacLaughlin DT, Riley KR, Martuza RL. Modulation of meningioma cell growth by sex steroid hormones in vitro. J Neurosurg 1985;62:757-62.
30. Kang SH, Cho HT, Devi S, et al. Antitumor effect of 2-methoxyestradiol in a rat orthotopic brain tumor model. Cancer Res 2006;66:11991-7.
31. Lis A, Ciesielski MJ, Barone TA, Scott BE, Fenstermaker RA, Plunkett RJ. 2-Methoxyestradiol inhibits proliferation of normal and neoplastic glial cells, and induces cell death, in vitro. Cancer Lett 2004;213:57-65. (Pubitemid 39118534)
32. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008: Cancer Incidence and Mortality Worldwide. Lyon, France: IARC Press; 2010.